Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Claire on +441494 818 025 or claire@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Claire Roberts
Director
claire@zenopa.com
+441494 818 025

Testimonials
I just wanted to express my thanks to the team at Zenopa for helping me gain an exciting new position with my new employer, you were a huge help.
Kate, 2011

Boehringer Ingelheim announces new diabetes collaboration

7 February 2012 00:00 in Pharmaceutical Company Product News


Boehringer Ingelheim has announced a new diabetes collaboration with GWT and the department of medicine of the Technische Universitat (TU) Dresden.

The agreement will see the pharmaceutical company work alongside GWT, a company based at the German university, in order to conduct research into the causes of the disease.

Attentions will be focused on the link between excessive blood glucose and other complications of the condition, with the ultimate aim of translating these findings into the development of innovative new therapies.

Six individual research projects have initially been defined by the industry-academia collaboration, which will take advantage of the expertise of all partners.

Professor Wolfgang Rettig, senior vice-president of research at Boehringer Ingelheim, said: "This research partnership builds upon the excellent, shared experience gained from our earlier collaboration with the TU Dresden."

Last week, Boehringer Ingelheim announced the launch of Lean-to Clinic, a new programme that aims to deliver drug products for clients at an accelerated rate.ADNFCR-8000103-ID-801285755-ADNFCR

Other news stories from 07/02/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd